Kidney International

FIGURES AND TABLES

FROM:

Systematic review of the impact of N-acetylcysteine on contrast nephropathy

NEESH PANNU, BRADEN MANNS, HELEN LEE and MARCELLO TONELLI

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Figure 1.

Funnel plot of effect size versus precision of effect size. The figure plots an index of effect size (ln relative risk) against its precision [standard error (SE) of ln relative risk]. There is an absence of small trials that found an increased incidence of contrast nephropathy associated with N-acetylcysteine (NAC).

Full figure and legend (5K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Figure 2.

Relative risk of contrast nephropathy associated with NAC: All identified trials. Relative risk refers to the risk of contrast nephropathy in the N-acetylcysteine (NAC) group, compared with control. The squares represent the point estimate of relative risk for each study, and their size is proportional to their weight in the pooled estimate of relative risk (represented by the diamond). Bars indicate 95% CI. Q = 26.3, P = 0.02.

Full figure and legend (52K)
BACK TO ARTICLE